MicroRNA-223-3p suppresses leukemia inhibitory factor expression and pinopodes formation during embryo implantation

Xiyuan Dong1, Cong Sui1, Kai Huang1

  • 1Reproductive Medicine Center, Tongji Hospital, Tongji Medicine College, Huazhong University of Science and Technology Jiefang Avenue 1095#, Wuhan 430030, People's Republic of China.

Insights

MicroRNA-223-3p suppresses embryo implantation by reducing LIF protein and inhibiting uterine pinopodes formation. This microRNA (miRNA) plays a key role in regulating gene expression during early pregnancy.

Area of Science:

  • Reproductive Biology
  • Molecular Endocrinology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression.
  • Leukemia inhibitory factor (LIF) is crucial for endometrial receptivity and embryo implantation.
  • A potential interaction between miR-223-3p and LIF suggests a role in implantation.

Purpose of the Study:

  • To investigate the role of miR-223-3p in regulating LIF expression and its impact on embryo implantation.
  • To elucidate the mechanism by which miR-223-3p influences endometrial receptivity.

Main Methods:

  • Bioinformatic analysis to identify miR-223-3p binding site on LIF 3'UTR.
  • Luciferase reporter assay to confirm direct binding and suppression.
  • In vivo studies involving uterine injection of miR-223-3p agonist in pregnant mice.
  • Histological examination of endometrial pinopodes formation.

Main Results:

  • Inverse expression of miR-223-3p and LIF protein in the mouse endometrium during the implantation window.
  • miR-223-3p directly binds to the LIF 3'UTR and suppresses LIF expression.
  • In vivo administration of miR-223-3p agonist significantly inhibited embryo implantation.
  • Overexpression of miR-223-3p compromised the formation of endometrial pinopodes.

Conclusions:

  • miR-223-3p negatively regulates LIF protein expression.
  • miR-223-3p impairs embryo implantation by suppressing LIF and compromising pinopodes formation.
  • These findings highlight miR-223-3p as a potential regulator of uterine receptivity.